Glipark PM 1mg/500mg/15mg Tablet SR
Marketer
Park Pharmaceuticals
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glipark PM 1mg/500mg/15mg Tablet SR
Metformin/Glimepiride/Pioglitazone extended-release tablets (1mg/500mg/15mg) offer combined blood glucose management. This medication, used alongside diet and exercise, improves glycemic control in adult type 2 diabetics. It enhances insulin effectiveness, reducing blood sugar. Dosage and frequency should strictly follow your physician's instructions. Take it with food to minimize gastrointestinal distress. Missed doses should be taken promptly unless nearing the next scheduled dose; avoid doubling the dose. Overdosage can cause hypoglycemia. Concurrent use with other antidiabetic drugs, alcohol, or skipped meals increases hypoglycemia risk; regular blood glucose monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, fractures, and respiratory infections. Inform your doctor of kidney, liver, or heart conditions before starting treatment. Pregnant or lactating individuals require prior medical consultation. Kidney function tests are necessary before initiation. Limit alcohol consumption to mitigate potential side effects.
Primary Ingredients of Glipark PM 1mg/500mg/15mg Tablet SR
No information provided. Therefore, no text can be rewritten.
Uses of Glipark PM 1mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Glipark PM 1mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glipark PM 1mg/500mg/15mg Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this extended-release tablet with a meal.
Common Side effects of Glipark PM 1mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glipark PM 1mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glipark PM 1mg/500mg/15mg Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this extended-release tablet with a meal.
How Glipark PM 1mg/500mg/15mg Tablet SR works:
Glipark PM 1mg/500mg/15mg Extended-Release Tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. This triple-drug approach enhances blood sugar management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Pioglitazone, a thiazolidinedione, further amplifies insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glipark PM 1mg/500mg/15mg SR tablets with alcohol is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Use of Glipark PM 1mg/500mg/15mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Glipark PM 1mg/500mg/15mg tablet is likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Impaired driving may result from excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should use Glipark PM 1mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Glipark PM 1mg/500mg/15mg SR tablets. Physician consultation is recommended. Regular kidney function monitoring is advised during treatment with this medication.
LiverCAUTION
Patients with liver impairment should use Glipark PM 1mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. Glipark PM 1mg/500mg/15mg SR tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Glipark PM 1mg/500mg/15mg Tablet SR :
Should you forget to take your Glipark PM 1mg/500mg/15mg Tablet SR, ingest it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual regimen. Avoid taking a double dose.
Facts to Know About Glipark PM 1mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently